Marksans Pharma – Is it still worth holding this stock in your Portfolio ?

Marksans Pharma – Is it still worth holding this stock in your Portfolio ?

Marksans Pharma is looking attractive at the current price levels considering the potential it has to go up by 100% in the coming months.

Pharma Multibagger screener

Let’s get into the detailed analysis

The stock has fallen almost 70% during Jan & Feb’2016 due to UK regulator (UK MHRA) warning letter about the company’s Goa plant deficiency in GMP but raised almost 50% from the low level post media reports about UK regulator allows conditional manufacturing at Goa unit

There are couple of interesting things emerged during analysis

Technical View

Despite the steep fall the stock found it’s support at the “cup pattern” breakout of Aug’2014. The significant factor about this cup pattern was it took years to form the pattern meaning it can be regarded as strong breakout  (which can be seen in the graph itself) and it forms a strong support as well.Technical Chart of Marksans Pharma

Fundamental View

Irrespective of the warnings from the UK regulator (majority of the revenue of Marksans Pharma comes from UK market), the fundamentals are still intact and the analysts consensus haven’t revised the forecast of company’s future (2017) earnings.

Equityboss Grades and Insights of Marksans Pharma

Considering the current market levels and technical/fundamental views; this stock can go upto 92 rupees in 3 months – 1 year time frame; On the flip side, the strong technical support lies at Rs.36 – if this level gives up, it is worth considering exit from the long position.

Answered by me in Quora.

DISCLAIMER EquityBoss or anyone involved with EquityBoss will not accept any liability for any trading loss or damage as a result of reliance on the information contained within this post including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with investing the financial markets, it is one of the riskiest investment forms possible. EquityBoss would like to remind you that the data contained in this post is neither necessarily real-time nor accurate. All stock prices, Fundamental/ Valuation indicators, buy/sell Signal are indicative and not appropriate for trading purposes. EquityBoss doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.
(Visited 540 times, 1 visits today)

Leave a Reply

%d bloggers like this: